Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Aug;35(2):151-66.
doi: 10.2165/00003088-199835020-00004.

Methodological issues in pharmacokinetic-pharmacodynamic modelling

Affiliations
Review

Methodological issues in pharmacokinetic-pharmacodynamic modelling

E Bellissant et al. Clin Pharmacokinet. 1998 Aug.

Abstract

This article presents the theoretical and practical aspects involved in the design and analysis of pharmacokinetic-pharmacodynamic modelling studies. The main features of the protocol of pharmacokinetic-pharmacodynamic studies are discussed with special focus on experimental designs in relation to individual and population approaches. Some basic pharmacodynamic models (such as linear, log-linear, hyperbolic and sigmoid models) are presented as well as more complex time-dependent models (effect compartment and physiological indirect response, tolerance models) which are required when the concentration-effect relationship shows a hysteresis loop. The methods of estimation, with special focus on the individual and populations approaches, are covered, along with the way pharmacodynamic models and methods of estimation can be applied to real data and the information required to criticise the results of modelling. We also present some real problems frequently encountered when performing pharmacokinetic-pharmacodynamic modelling and give some potential solutions (problems with hysteresis loops, lack of convergence, problems with residuals). The last section discusses the significance of pharmacodynamic parameters.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharmacokinet Biopharm. 1984 Oct;12(5):545-58 - PubMed
    1. Ann N Y Acad Sci. 1963 May 10;108:182-94 - PubMed
    1. Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53 - PubMed
    1. Pharm Res. 1987 Apr;4(2):86-91 - PubMed
    1. J Pharm Pharmacol. 1964 Mar;16:137-57 - PubMed

LinkOut - more resources